Research Article

Endovascular therapy of peripheral arterial disease involving iliac artery and distal lower extremity arteries

Volume: 7 Number: 3 September 30, 2020
TR EN

Endovascular therapy of peripheral arterial disease involving iliac artery and distal lower extremity arteries

Abstract

Objective: Methods of endovascular therapy have been increasingly used in addition to conventional surgical approaches in the treatment of peripheral arterial diseases. This study aims to evaluate to the endovascular treatment methods that we use in patients with peripheral arterial disease. Materials and Methods: We retrospectively analyzed twenty-four of patients were treated with endovascular method. Nineteen of the patients had intermittent claudication, 4 had rest pain and one patient with bilateral popliteal artery aneurysms had pain at the back of bilateral knee joints. Twenty patients were male and 4 were female. The mean age was was 55,26± 10,95( 38-81) years. Evaluations included clinical assesment according to Fontaine stages. Doppler examinations with ankle-brachial index (ABI) and bilateral lower extremity arteriograms. Ten of the patients who underwent endovascular therapy had a lesion in TASCII-A group, 5 had a TASCII-B lesion, and TASCII-C lesions were present in 9 patients. All patients were followed prospectively with arterial duplex scan. Results: Bioabsorbable stent was implanted in 11 patients. Balloon angioplasty was performed in 3 patients. A self-expandable nitinol stent was deployed in 3 patients. Subintimal balloon angioplasty was performed in 6 patients. An aneurysm repair was performed with stent graft in 1 patient who had bilateral popliteal and right anterior tibial artery aneurysms. Initial technical and hemodynamic success was achieved in 100% of cases. Preoperative 0,67±0,13 (0,4-0,95) and after one year later 0,94±0,07 (0,8-1) analysis for ABI revealed statistically significant (p<0,05). Conclusion: Urgent success was achieved in all patients. Patient symptoms were markedly improved at the postoperative period and the patients with event-free postoperative clinical course were discharged with complete recovery. No vascular problems were observed during the follow-up of the patients.

Keywords

References

  1. Referans1. Dormandy J, Rutherford RB: Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31(Pt 2):S1-S296, 2003
  2. Referans2. Amanvermez Şenarslan, D , YILDIRIM, F , TETİK, Ö . "Evaluation of Early and Mid-term Results of TEVAR Procedures with Various Etiology."Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi6(2019 ): 283-288
  3. Referans3. Chisci E, Perulli A, Iacoponi F, Setacci F, de Donato G, Palasciano G, et al. Benefit of revascularisation to critical limb ischaemia patients evaluated by a patientoriented scoring system. Eur J Vasc Endovasc Surg 2012;43:540-7.
  4. Referans4. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45:Suppl S: S5–S67.
  5. Referans5. Go AS, Mozaffarian D, Roger VL, et al; American Heart Asso¬ciation Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics – 2014 update: a report from the American Heart Association. Circulation. 2014;129(3):399–410.
  6. Referans6. Giles KA, Pomposelli FB, Spence TL, et al. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consen¬sus class to outcome in 176 limbs. J Vasc Surg. 2008;48(1):128–136.
  7. Referans7. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosy¬lated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141(6):421–431.
  8. Referans8. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atheroscle¬rotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S1–S45.

Details

Primary Language

English

Subjects

Cardiovascular Surgery

Journal Section

Research Article

Publication Date

September 30, 2020

Submission Date

June 6, 2020

Acceptance Date

September 17, 2020

Published in Issue

Year 2020 Volume: 7 Number: 3

APA
Surer, S., Beşir, Y., Rodoplu, O., & Tetik, Ö. (2020). Endovascular therapy of peripheral arterial disease involving iliac artery and distal lower extremity arteries. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal, 7(3), 395-400. https://doi.org/10.34087/cbusbed.748516
AMA
1.Surer S, Beşir Y, Rodoplu O, Tetik Ö. Endovascular therapy of peripheral arterial disease involving iliac artery and distal lower extremity arteries. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal. 2020;7(3):395-400. doi:10.34087/cbusbed.748516
Chicago
Surer, Suleyman, Yüksel Beşir, Orhan Rodoplu, and Ömer Tetik. 2020. “Endovascular Therapy of Peripheral Arterial Disease Involving Iliac Artery and Distal Lower Extremity Arteries”. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal 7 (3): 395-400. https://doi.org/10.34087/cbusbed.748516.
EndNote
Surer S, Beşir Y, Rodoplu O, Tetik Ö (September 1, 2020) Endovascular therapy of peripheral arterial disease involving iliac artery and distal lower extremity arteries. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal 7 3 395–400.
IEEE
[1]S. Surer, Y. Beşir, O. Rodoplu, and Ö. Tetik, “Endovascular therapy of peripheral arterial disease involving iliac artery and distal lower extremity arteries”, CBU-SBED: Celal Bayar University-Health Sciences Institute Journal, vol. 7, no. 3, pp. 395–400, Sept. 2020, doi: 10.34087/cbusbed.748516.
ISNAD
Surer, Suleyman - Beşir, Yüksel - Rodoplu, Orhan - Tetik, Ömer. “Endovascular Therapy of Peripheral Arterial Disease Involving Iliac Artery and Distal Lower Extremity Arteries”. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal 7/3 (September 1, 2020): 395-400. https://doi.org/10.34087/cbusbed.748516.
JAMA
1.Surer S, Beşir Y, Rodoplu O, Tetik Ö. Endovascular therapy of peripheral arterial disease involving iliac artery and distal lower extremity arteries. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal. 2020;7:395–400.
MLA
Surer, Suleyman, et al. “Endovascular Therapy of Peripheral Arterial Disease Involving Iliac Artery and Distal Lower Extremity Arteries”. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal, vol. 7, no. 3, Sept. 2020, pp. 395-00, doi:10.34087/cbusbed.748516.
Vancouver
1.Suleyman Surer, Yüksel Beşir, Orhan Rodoplu, Ömer Tetik. Endovascular therapy of peripheral arterial disease involving iliac artery and distal lower extremity arteries. CBU-SBED: Celal Bayar University-Health Sciences Institute Journal. 2020 Sep. 1;7(3):395-400. doi:10.34087/cbusbed.748516